ITCI - Intra-Cellular Therapies, Inc.
131.87
-0.050 -0.038%
Share volume: 16,062,974
Last Updated: 04-01-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$131.92
-0.05
0.00%
Summary score
24%
Profitability
25%
Dept financing
4%
Liquidity
75%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.92%
Return on assets
-9.9%
Return on sales
-3966.41%
Return on invested capital
243.96%
Total debt ratio
10.9%
Debt ratio change over timeo
0%
Current Ratio
18.73%
Quick Ratio
12.57%
Cash Position Ratio
3.1%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.99%
Return on assets
-13.63%
Return on sales
-3966.41%
Return on invested capital
335.61%
Total debt ratio
16.49%
Debt ratio change over timeo
0%
Current Ratio
9.84%
Quick Ratio
12.57%
Cash Position Ratio
3.69%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.79%
Return on assets
-14.71%
Return on sales
-3402.45%
Return on invested capital
356.23%
Total debt ratio
13.93%
Debt ratio change over time
0%
Current Ratio
10.4%
Quick Ratio
10.34%
Cash Position Ratio
2.9%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ITCI | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -10.92% | 17.45% | 4.69% | -3.05% |
| Return on assets | -9.9% | 3.37% | 3.35% | 3.6% |
| Return on sales | -3966.41% | 23.96% | 25.96% | 32.14% |
| Return on invested capital | 243.96% | 5.2% | 4.37% | 5.09% |
| Profitability | 25% | 68% | 51% | 51% |
| Total debt ratio | 10.9% | 77% | 57.66% | 101.18% |
| Debt ratio change over time | 0% | 0% | 10.55% | 69.81% |
| Dept financing | 3% | 19% | 18% | 50% |
| Current Ratio | 9.84% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 12.57% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 3.69% | 0.17% | 0.53% | 1.48% |
| Liquididy | 75% | 7% | 10% | 11% |
| Short-term ratios | ITCI | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -15.99% | 44.06% | 6.24% | -25.62% |
| Return on assets | -13.63% | 3.88% | 3.22% | 3.26% |
| Return on sales | -3966.41% | 27.04% | 24.93% | 31.22% |
| Return on invested capital | 335.61% | 9.69% | 4.96% | 8.14% |
| Profitability | 25% | 72% | 45% | 47% |
| Total debt ratio | 16.49% | 91.8% | 61.39% | 105.33% |
| Debt ratio change over time | 0% | 0% | 12.93% | 15.97% |
| Dept financing | 4% | 22% | 35% | 50% |
| Current Ratio | 9.84% | 1.16% | 1.27% | 2.08% |
| Quick Ratio | 12.57% | 0.89% | 1.01% | 1.96% |
| Cash Position Ratio | 3.69% | 0.17% | 0.53% | 1.48% |
| Liquididy | 75% | 6% | 9% | 19% |